RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cellular and Molecular Life Sciences

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00018-013-1376-3PMID 23736835PMCID PMC4098834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Derailed estrogen signaling and breast cancer: an authentic couple.

  2013cited by this paper
• Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells

  2012cited by this paper
• Emerging roles of the ubiquitin-proteasome system in the steroid receptor signaling

  2012cited by this paper
• Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis.

  2012cited by this paper
• Post-translational modifications of nuclear receptors and human disease

  2012cited by this paper
• Emerging significance of estrogen cancer coregulator signaling in breast cancer.

  2012cited by this paper
• ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4

  2012cited by this paper
• Role of SUMOylation in Full Antiestrogenicity

  2012cited by this paper
• PES1 promotes breast cancer by differentially regulating ERα and ERβ.

  2012cited by this paper
• Emerging significance of estrogen receptor coregulator signaling in breast cancer

  2012cited by this paper
• A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.

  2012cited by this paper
• SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.

  2012cited by this paper
• Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy

  2011cited by this paper
• Clinical significance of estrogen receptor phosphorylation.

  2011cited by this paper
• Cells of origin in cancer

  2011cited by this paper
• Stability of estrogen receptor status in breast carcinoma

  2011cited by this paper
• Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer.

  2011cited by this paper
• The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.

  2011cited by this paper
• Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks.

  2011cited by this paper
• Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer

  2011cited by this paper
• Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.

  2011cited by this paper
• KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis

  2011cited by this paper
• 17β-Estradiol Enhances Breast Cancer Cell Motility and Invasion via Extra-Nuclear Activation of Actin-Binding Protein Ezrin

  2011cited by this paper
• Effects of estrogen on the proportion of stem cells in the breast

  2011cited by this paper
• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

  2011cited by this paper
• Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Repressor of estrogen receptor activity (REA) is essential for mammary gland morphogenesis and functional activities: studies in conditional knockout mice.

  2011cited by this paper
• Distinct stem cells contribute to mammary gland development and maintenance

  2011cited by this paper
• Pioneer transcription factors: establishing competence for gene expression.

  2011cited by this paper
• Hormone action in the mammary gland.

  2010cited by this paper
• The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype

  2010cited by this paper
• Genomic analyses of hormone signaling and gene regulation.

  2010cited by this paper
• Regulation of aromatase induction by nuclear receptor coregulator PELP1.

  2010cited by this paper
• Low SAFB levels are associated with worse outcome in breast cancer patients

  2010cited by this paper
• Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.

  2010cited by this paper
• The Actin-binding Protein, Actinin Alpha 4 (ACTN4), Is a Nuclear Receptor Coactivator that Promotes Proliferation of MCF-7 Breast Cancer Cells*

  2010cited by this paper
• Estrogen Inhibits Transforming Growth Factor β Signaling by Promoting Smad2/3 Degradation*

  2010cited by this paper
• Regulation of Krüppel-like Factor 4 by the Anaphase Promoting Complex Pathway Is Involved in TGF-β Signaling*

  2010cited by this paper
• Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis.

  2010cited by this paper
• Metastatic behavior of breast cancer subtypes.

  2010cited by this paper
• Control of mammary stem cell function by steroid hormone signalling

  2010cited by this paper
• Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

  2010cited by this paper
• BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

  2010cited by this paper
• Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.

  2010cited by this paper
• Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.

  2010cited by this paper
• High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer

  2010cited by this paper
• Estrogen stimulation of cell migration involves multiple signaling pathway interactions.

  2010cited by this paper
• MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells.

  2010cited by this paper
• Mammosphere‐derived gene set predicts outcome in patients with ER‐positive breast cancer

  2009cited by this paper
• Regulating the stability of TGFβ receptors and Smads

  2009cited by this paper
• Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogen.

  2009cited by this paper
• Ski and SnoN, potent negative regulators of TGF-β signaling

  2009cited by this paper
• Dual effects of TGF-β on ERα-mediated estrogenic transcriptional activity in breast cancer

  2009cited by this paper
• Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen

  2009cited by this paper
• The DEAD box protein p72 regulates ERα-/Estrogen-dependent transcription and cell growth, and is associated with improved survival in ERα positive breast cancer

  2009cited by this paper
• Biochemical analyses of nuclear receptor-dependent transcription with chromatin templates.

  2009cited by this paper
• CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions

  2009cited by this paper
• Membrane oestrogen receptor α signalling to cell functions

  2009cited by this paper
• Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

  2009cited by this paper
• S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell Proliferation*

  2009cited by this paper
• Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells

  2009cited by this paper
• Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells.

  2009cited by this paper
• An Oestrogen Receptor α-bound Human Chromatin Interactome

  2009cited by this paper
• Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition.

  2009cited by this paper
• Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.

  2009cited by this paper
• Ski co‐repressor complexes maintain the basal repressed state of the TGF‐β target gene, SMAD7, via HDAC3 and PRMT5

  2009cited by this paper
• The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.

  2009cited by this paper
• Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells.

  2009cited by this paper
• Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair.

  2009cited by this paper
• The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis.

  2009cited by this paper
• Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

  2009cited by this paper
• Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits?

  2009cited by this paper
• The silent estrogen receptor--can we make it speak?

  2009cited by this paper
• Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation.

  2008cited by this paper
• Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-α activity

  2008cited by this paper
• Proliferation of breast cancer cells: regulation, mediators, targets for therapy.

  2008cited by this paper
• Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.

  2008cited by this paper
• Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists.

  2008cited by this paper
• Minireview: nuclear receptors and breast cancer.

  2008cited by this paper
• Repression of transcriptional activity of estrogen receptor alpha by a Cullin3/SPOP ubiquitin E3 ligase complex.

  2008cited by this paper
• HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb.

  2008cited by this paper
• DNA Oxidation as Triggered by H3K9me2 Demethylation Drives Estrogen-Induced Gene Expression

  2008cited by this paper
• The AIB1 Oncogene Promotes Breast Cancer Metastasis by Activation of PEA3-Mediated Matrix Metalloproteinase 2 (MMP2) and MMP9 Expression

  2008cited by this paper
• Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase.

  2008cited by this paper
• Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements*

  2008cited by this paper
• Targeting Src in breast cancer.

  2008cited by this paper
• Nuclear receptor coregulators and human disease.

  2008cited by this paper
• Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1.

  2008cited by this paper
• Regulation of estrogen rapid signaling through arginine methylation by PRMT1.

  2008cited by this paper
• A repressive role for prohibitin in estrogen signaling.

  2008cited by this paper
• Decreased BRCA1 Confers Tamoxifen Resistance in Breast Cancer Cells by Altering Estrogen Receptor-Coregulator Interactions

  2008cited by this paper
• The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer

  2008cited by this paper
• Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals.

  2008cited by this paper
• Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells.

  2008cited by this paper
• Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase

  2007cited by this paper
• Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors

  2007cited by this paper
• Reversal of the Estrogen Receptor–Negative Phenotype in Breast Cancer and Restoration of Antiestrogen Response

  2007cited by this paper

• Incorporation of network pharmacology, molecular docking, survival, density functional theory, and experimental studies to explore the potential key targets of formononetin by TERT-mediated anti-cancer effects in MCF-7 breast cancer.

  2026cites this paper
• Increased TGF-β signaling during antiestrogen therapy in triple-negative breast cancer cells.

  2025cites this paper
• Targeting the feminized nature of prostate cancer exploring estrogen-driven metabolic reprogramming and its therapeutic intervention: а narrative review

  2025cites this paper
• An Update and Translational Perspective in Genetics and Genomics of Breast Cancer

  2025influential citation
• Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis

  2024cites this paper
• Enforcing the antioxidant properties of blackberries against breast cancer by activating different cell signaling mechanisms: An updated review

  2024cites this paper
• Therapeutic significance of long noncoding RNAs in estrogen receptor‐positive breast cancer

  2024cites this paper
• Analysis of Essential Oils Components from Aromatic Plants Using Headspace Repellent Method against Aedes aegypti Mosquitoes

  2023cites this paper
• Structure-Based Multi-Targeted Molecular Docking and Dynamic Simulation of Soybean-Derived Isoflavone Genistin as a Potential Breast Cancer Signaling Proteins Inhibitor

  2023cites this paper
• Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells

  2023cites this paper
• Breast cancer and the molecular mechanism of estrogen signaling

  2023cites this paper
• Innovative Thiosemicarbazones that Induce Multi-Modal Mechanisms to Down-Regulate Estrogen-, Progesterone-, Androgen- and Prolactin-Receptors in Breast Cancer.

  2023cites this paper
• Structure-based virtual screening of anti-breast cancer compounds from Artemisia absinthium—insights through molecular docking, pharmacokinetics, and molecular dynamic simulations

  2023cites this paper
• Modeling survival response using a parametric approach in the presence of multicollinearity

  2022cites this paper
• Evaluation of Salivary KCNJ3 mRNA Levels in Breast Cancer: A Case–control Study and in silico Analysis

  2022cites this paper
• Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications.

  2022cites this paper
• Network pharmacology-based study to identify the significant pathways of Lentinula edodes against cancer.

  2022cites this paper
• Identification of Diagnostic Markers for Breast Cancer Based on Differential Gene Expression and Pathway Network

  2022cites this paper
• A Flexible and Robust Approach to Analyze Survival Systems in the Presence of Extreme Observations

  2021cites this paper
• Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer

  2020cites this paper
• Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells

  2019cites this paper
• New dimensions in calix[4]pyrrole: the land of opportunity in supramolecular chemistry

  2019cites this paper
• Brain Cancer Receptors and Targeting Strategies

  2019cites this paper
• Basic helix-loop-helix transcription factor Twist1 is a novel regulator of anterior gradient protein 2 homolog (AGR2) in breast cancer.

  2019cites this paper
• The effect of TGF-β signaling on regulating proliferation of uterine leiomyoma cell via ERα signaling activated by bisphenol A, octylphenol and nonylphenol in vitro

  2018cites this paper
• Review of the Ubiquitin Role in DNA Repair and Tumorigenesis, with Emphasis in Breast Cancer Treatment; Current Data and Future Options

  2018cites this paper
• Expression of ERβ gene in breast carcinoma and the relevance in neoadjuvant therapy

  2017cites this paper
• Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.

  2017cites this paper
• Differential pro-apoptotic effect of allicin in oestrogen receptor-positive or -negative human breast cancer cells

  2016cites this paper
• How interacting pathways are regulated by miRNAs in breast cancer subtypes

  2016cites this paper
• Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro

  2015cites this paper
• Zirkulierende Tumorzellen bei Östrogenrezeptor-positiven Brustkrebspatientinnen in verschieden klinischen Stadien

  2015cites this paper
• A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models

  2015cites this paper
• Polimorfismos nos genes ESR1, ESR2 e MTHFR como fatores de risco do câncer de mama esporádico

  2015influential citation
• Krüppel-like factors are effectors of nuclear receptor signaling.

  2014cites this paper
• GPER mediates activation of HIF1α/VEGF signaling by estrogens.

  2014cites this paper
• An interspecies conserved motif of the mouse immune system-released activating agent (ISRAA) induces proliferative effects on human cells

  2014cites this paper
• SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy.

  2013cites this paper